Home
>
National Drug Code (NDC)
>
RECOMBIVAX HB
RECOMBIVAX HB - 0006-4995-41 - (Hepatitis B Vaccine (Recombinant))
Drug Information of RECOMBIVAX HB
| Product NDC: | 0006-4995 |
| Proprietary Name: | RECOMBIVAX HB |
| Non Proprietary Name: | Hepatitis B Vaccine (Recombinant) |
| Active Ingredient(s): | 10 ug/mL & nbsp; Hepatitis B Vaccine (Recombinant) |
| Administration Route(s): | INTRAMUSCULAR; SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of RECOMBIVAX HB
| Product NDC: | 0006-4995 |
| Labeler Name: | Merck Sharp & Dohme Corp. |
| Product Type: | VACCINE |
| FDA Application Number: | BLA101066 |
| Marketing Category: | BLA |
| Start Marketing Date: | 19860723 |
Package Information of RECOMBIVAX HB
| Package NDC: | 0006-4995-41 |
| Package Description: | 10 VIAL, SINGLE-DOSE in 1 CARTON (0006-4995-41) > 1 mL in 1 VIAL, SINGLE-DOSE |
NDC Information of RECOMBIVAX HB
| NDC Code | 0006-4995-41 |
| Proprietary Name | RECOMBIVAX HB |
| Package Description | 10 VIAL, SINGLE-DOSE in 1 CARTON (0006-4995-41) > 1 mL in 1 VIAL, SINGLE-DOSE |
| Product NDC | 0006-4995 |
| Product Type Name | VACCINE |
| Non Proprietary Name | Hepatitis B Vaccine (Recombinant) |
| Dosage Form Name | INJECTION, SUSPENSION |
| Route Name | INTRAMUSCULAR; SUBCUTANEOUS |
| Start Marketing Date | 19860723 |
| Marketing Category Name | BLA |
| Labeler Name | Merck Sharp & Dohme Corp. |
| Substance Name | HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN |
| Strength Number | 10 |
| Strength Unit | ug/mL |
| Pharmaceutical Classes | Inactivated Hepatitis B Virus Vaccine [EPC],Actively Acquired Immunity [PE],Hepatitis B Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient] |
